Current WADA status should be verified for competitive athletes
Who AOD-9604 Is For and Who Should Avoid It AOD-9604 is a research compound
The goal is to allow enough time for the slow process of ligament and tendon remodeling to occur
By contrast, while fibroblast growth factor (FGF) potential to induce skeletal muscle angiogenesis has been extensively investigated (for review see, i.e., [133]), the practical significance of such FGF, and even vascular endothelial growth factor (VEGF) [134], for muscle healing means an effect that is mostly limited to direct local administration combined with different modes of delivery [135]
Athletes report incorporating it after workouts, during rehab phases, or while training through high-volume periods where strain on ligaments and tendons becomes a concern
Experimental vascular studies indicate that BPC-157 modulates endothelial nitric oxide synthase activity by altering the interaction between endothelial nitric oxide synthase and its regulatory binding partner caveolin-1 [1][2]